Introduction
The peculiar structure and biochemical features of camelid and shark hcAbs
Molecular cloning and reformatting of camelid and shark sdAbs
Single domain antibodies in immunity
Target | Application | Source of sdAb | Reference |
---|---|---|---|
Membrane proteins
| |||
ART2.2 | Blocking T-cell ecto-enzyme, treatment of auto-immune disease | Immune llama | [29] |
CD16 | Activation of NK cells | Immune llama | [36] |
α3β1 Integrin VLA-3 | Block leukocyte-matrix adhesion | Immune llama | [37] |
α 2,3 Sialoglyco-protein | Crossing the blood brain barrier | Non-immune llama | |
EGFR | In vivo imaging, cancer immunotherapy | Immune camel, immune llama | |
CEA | Cancer immunotherapy | Immune llama | [40] |
MUC 1 | Tumor targeting | Immune camel and llama | |
CD105 (endoglin) | Tumor targeting | Immune camel | [46] |
Secretory proteins
| |||
TNFα | Cytokine neutralization | Immune llama and alpaca | |
PSA | Cancer diagnosis | Immune dromedary | |
von Willebrand factor | Blocking blood clotting | Immune llama | [50] |
Amyloid Aβ peptide | Amyloid aggregation | Immune dromedary and alpaca | |
Lysozyme | Amyloidosis | Immune dromedary | |
IgG | Depletion of auto-Abs | Immune llama | [55] |
Serum albumin | Bispecific sdAbs, increase serum half-life | Immune llama | |
Intracellular proteins
| |||
Bax | Inhibiting apoptosis | Non-immune llama | [18] |
HIF-1α | Hypoxia response | Non-immune llama | |
PABPN1 | Aggregation disorders | Immune and non-immune llama | |
Vaccine enhancement
| |||
Lumazine synthase | Molecular assembly vaccines | Immune llama | Urrutia, Danquah et al. (unpublished) |
Molecular mimicry
| |||
Immunoglobulin idiotype | Molecular mimicry | Immune llama, non-immune shark |
Targeting leukocyte ecto-enzymes
Targeting other cell surface proteins with sdAbs
Targeting cytokines with sdAbs
Targeting other soluble proteins with sdAbs
Targeting intracellular proteins with sdAbs—intrabodies, translocation peptides, and CDR3 peptide mimetics
Molecular assembly vaccines
sdAbs as tools for molecular mimicry
Single domain antibodies in infection
Targeting protein toxins and poisons with sdAbs
Target | Application | Source of sdAb | Reference |
---|---|---|---|
Toxins
| |||
Salmonella SpvB toxin | Neutralization | Immune llama | Alzogaray et al. (unpublished) |
Cholera toxin, staphylococcus enterotoxin A, ricin, botulinum neurotoxin A | Biosensor | Non-immune llama and non-immune shark | |
LPS | Depletion of endotoxin | Non-immune llama | [72] |
Scorpion toxin | Neutralization | Immune camel and dromedary | |
Scorpion/conus toxins | Neutralization | Immune shark | Licea et al. (unpublished) |
Alpha-cobrotoxin | Antivenom development | Non-immune llama | [76] |
Mycotoxin | Detecting toxin contamination | Immune llama | [78] |
Viruses
| |||
HIV env | Neutralization | Immune llama | [84] |
Rotavirus, gp6 | Absorption of virus on lactobacillus | Immune llama | |
FMDV | Neutralization | Immune llama | |
Hepatitis B | Blocking virus secretion | Immune llama | [20] |
Lactococcus phage receptor binding protein | Protect milk fermentation | Immune llama | |
Porcine retrovirus | Neutralize endogenous retrovirus in transgenic pigs | Immune llama | [91] |
Marburg virus | Biosensor/diagnosis | Non-immune llama | [92] |
Bacteria
| |||
Streptococcus mutans | Reduce dental caries | Immune llama | |
E. coli F4 fimbriae | Treat pig diarrhea | Immune llama | |
EspI:EpsJ pseudopilin | Chaperone assisted crystallography | Immune llama | [97] |
GspD secretin | Chaperone assisted crystallography | Immune llama | [96] |
β-lactamase | Antibiotic enhancement | Immune dromedary | |
Parasites
| |||
Variable surface glycoprotein (oligomannose) | Trypanosome drug delivery | Immune dromedary | |
Trans-sialidase | Trypanosomiasis diagnosis | Immune llama | [103] |
Trypanosomes | Infectome tools | Immune dromedary | [102] |
AMA1 | Malaria diagnosis | Immune shark | [122] |
Taenia solium
| Tapeworm diagnosis | Immune dromedary | [104] |